AB Science to present results from its Phase 2B/3 AB07002 study in progressive forms of multiple sclerosis at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting AB Science SA (Euronext - FR0010557264 - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback